August 7, 2022
Breakthrough T1D Statement on the Passage of the Inflation Reduction Act
July 18, 2022
Breakthrough T1D Remembers the Life and Legacy of Steve Davis
July 12, 2022
Star Athletes to Hit the Court at The Basketball Tournament (TBT) in Support of Breakthrough T1D
July 11, 2022
Breakthrough T1D Statement on the Acquisition of ViaCyte by Vertex Pharmaceuticals
June 23, 2022
NBA Coach Caron Butler and Breakthrough T1D Raise Awareness About Type 1 Diabetes and Early Detection to Improve Health Equity
June 22, 2022
Breakthrough T1D Supports Proposed Senate Legislation Addressing the National Insulin Affordability and Accessibility Crisis
June 18, 2022
Breakthrough T1D Statement on the CDC Recommendation of Covid-19 Vaccines for Children 6 months +
June 16, 2022
Breakthrough T1D Announces the Appointment of David M. Harlan, MD, as Director of the Breakthrough T1D Center of Excellence in New England
June 9, 2022
Breakthrough T1D Celebrates Progress in Type 1 Diabetes Research at the American Diabetes Association 82nd Scientific Sessions
June 3, 2022
Breakthrough T1D and Neurodon, in Collaboration with the Indiana University School of Medicine and the Universite Libre de Bruxelles, Partner to Advance Small Molecules Targeting a Key Pathway in Type 1 Diabetes Progression
